生理食塩水の世界市場 - 2023年～2030年

生理食塩水の概要

生理食塩水は正常食塩水とも呼ばれ、0.9％の塩化ナトリウム溶液です。等張液であることから生理食塩水と呼ばれ、浸透圧は血液や涙などの体液の浸透圧と同等です。生理食塩水を作るには、純塩9gを蒸留水1リットルに溶かします。原料や調製法はシンプルだが、標準的な生理食塩水を作るためには、食塩の原料から、清潔、不純物のないこと、汚染されていないこと、水分がないことなど、多くの要素を確保する必要があります。

また、生理食塩水の用途は多く、輸液用生理食塩水の形態は、嘔吐や下痢など、体内に水分や電解質を補給する必要がある場合に使用されます。生理食塩水を点滴する場合、医師は治療効果のある薬剤を生理食塩水に処方することができ、点滴速度を適切なレベルに調整することで、薬剤が患者の体内に入り、最適な濃度になるようにします。生理食塩水は表面の不純物を取り除き、目に潤いを与え、和らげます。

市場力学：促進要因

外科手術における生理食塩水の採用増加

外科手術における生理食塩水の採用増加は、予測期間中、市場を牽引すると予想されます。生理食塩水は、水分補給、電解質バランス、血液量を維持するために、外科手術中の静脈内輸液として一般的に使用されています。生理食塩水は、感染予防と治癒促進のため、手術中の傷口の洗浄と灌流に使用されます。生理食塩水は、電気手術のような特定の外科手術において導電性媒体として機能します。

手術件数の増加は、生理食塩水の需要を増加させると予想されています。例えば、米国国立衛生研究所（NIH）によると、2020年、世界全体で毎年3億1,000万件、米国では約4,000万～5,000万件、欧州では約2,000万件の大手術が行われています。これらの患者のうち1～4％が死亡し、最大15％が術後に重篤な病的状態に陥り、5～15％が30日以内に再入院すると推定されています。

さらに、手術中、外科医は臓器移植のような様々な処置の際に組織を洗浄するために生理食塩水を使用します。生理食塩水は等張性、つまり人間の細胞と同じような塩分濃度であるため、外科手術時を含む様々な用途に安全に使用できます。生理食塩水は、その組成から副作用のリスクが低く、外科手術の現場で好んで使用されます。さらに、生理食塩水は手術中に投与される薬剤の希釈剤としても使用されています。

さらに、創傷、脱水、その他の急性健康障害の有病率の増加、生理食塩水に関する認知度の向上、様々な用途での生理食塩水の採用増加などが、予測期間中に市場を牽引すると予想される要因となっています。

阻害要因

気管内吸引の前に生理食塩水を注入すると、脱飽和、気管支痙攣、呼吸困難、人工呼吸器関連肺炎などのデメリットが生じることが診療ガイドラインで示されているように、生理食塩水に関連する副作用などの要因が市場を阻害すると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 外科手術における採用の増加
  • 抑制要因
    • 生理食塩水の副作用
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• パイプライン分析
• アンメットニーズ
• DMI意見

第6章 COVID-19分析

第7章 包装タイプ別

• プラスチックボトル
• ガラス瓶
• フレキシブルバッグ

第8章 用途別

• 脱水
• 代謝性アルカローシス
• 軽度のナトリウム欠乏
• 創傷洗浄
• 皮膚の擦り傷と火傷
• その他

第9章 エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他のアジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Enzo Life Sciences, Inc.
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Adipogen Life Sciences
• Geno Technology Inc.
• LABORATORIOS ERN, S.A.
• Grifols, S.A.
• Schwitz Biotech
• Eurocrit Labs International
• Cepham Life Sciences

第13章 付録

Overview

Physiological saline also called normal saline solution, is a 0.9% sodium chloride solution, called physiological because it is an isotonic solution, with an osmotic pressure equivalent to that of body fluids such as blood and tears under normal conditions. To create physiological saline, dissolve 9g of pure salt with 1 liter of distilled water. Although the ingredients and preparation are simple, in order to create a standard physiological saline product, it is necessary to ensure a lot of factors from salt raw materials to ensure cleanliness, no impurities, no contamination and no water.

Moreover, physiological saline has many uses, the form of physiological saline solution for infusion is used in cases where the body needs to replenish water and electrolytes such as when vomiting and diarrhea. When infusion, the doctor can prescribe to physiological saline solution drugs with therapeutic effects, the infusion rate is adjusted to the appropriate level so that the drug enters the patient's body to reach the optimal concentration. Physiological saline helps clean surface impurities and moisturizes and also soothes the eyes.

Market Dynamics: Drivers

Increasing adoption of physiological saline in surgical procedures

The increasing adoption of physiological saline in surgical procedures is expected to drive the market over the forecast period. Physiological saline is commonly used as an intravenous fluid during surgical procedures to maintain hydration, electrolyte balance, and blood volume. Saline is used for cleaning and irrigating wounds during surgery to prevent infection and promote healing. Physiological saline serves as a conductive medium in certain surgical procedures like electrosurgery.

The increasing number of surgeries is expected to increase the demand for physiological saline. For instance, according to the National Institute of Health (NIH), 2020, globally, a staggering 310 million major surgeries are performed each year, around 40 to 50 million in the USA and 20 million in Europe. It is estimated that 1-4% of these patients will die, up to 15% will have serious postoperative morbidity and 5-15% will be readmitted within 30 days.

Moreover, during the surgery, surgeons use saline to flush tissues during various procedures like organ transplants. Physiological saline is isotonic, meaning it has a similar salt concentration as human cells, making it safe for various applications including during surgical procedures. Its composition reduces the risk of adverse reactions or side effects, making it a preferred choice in surgical settings. Additionally, saline is also used as a diluent for medications administered during surgery.

Further, the increasing prevalence of wounds, dehydration and other acute health disorders, increasing awareness about the physiological salines and increasing adoption of the physiological salines in various applications are the factors expected to drive the market over the forecast period.

Restraints

Factors such as side effects associated with the physiological saline like practice guidelines indicate that normal saline instillation before endotracheal suctioning has more disadvantages, such as desaturation, bronchospasm, dyspnea and ventilator-associated pneumonia are expected to hamper the market.

Segment Analysis

The global physiological saline market is segmented based on packaging type, application, end-user and region.

The plastic bottle segment accounted for approximately 39.8% of the physiological saline market share

The plastic bottle segment is expected to hold the largest market share over the forecast period. The plastic bottles can be manufactured to meet stringent requirements for sterility, ensuring the safety of the saline solution. Even these plastic saline bottles are more affordable than the others. Also, plastic bottles are lightweight, which makes them easy to handle and transport, which is crucial in medical settings.

Additionally, plastic bottles are easy to squeeze by facilitating the controlled administration of saline solutions during surgical and other procedures. Plastic bottles are often designed for single use, this reduces the risk of contamination and simplifies disposal after use. Transparent or translucent plastic bottles allow to visually inspect the contents for clarity and purity. Plastic bottles are often designed for single use, reducing the risk of contamination.

Further, their wide availability and acceptability helps to hold the largest market share. Plastic saline bottles are durable and less prone to breakage than other packaging devices such as glass containers, this further reduces the risk of accidents in hospital and clinical environments. In addition, their wide adoption also increases the demand for the plastic saline bottle.

Geographical Analysis

North America accounted for approximately 39.8% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption. North America especially the United States is a hub for its presence of major players such as pharmaceutical companies and medical device companies. The presence of major players actively focussing on manufacturing more amount of physiological salines, further recovers the shortages of the salines in the region.

Furthermore, increasing adoption of the physiological salines in the region is also expected to drive the market in the region. The region is known for the increasing aging population and the increasing prevalence of many acute care disorders, further increasing the demand for the adoption of salines. Additionally, the region also experiences a high volume of medical procedures, including surgeries, which contributes to the demand for physiological saline used in various medical applications.

For instance, according to the NPR Organization, IV fluids are among the most common medical interventions worldwide. Several kinds are available, but one called normal saline or physiological saline is by far the most popular. Over 200 million liters are used every year in the United States for various medical procedures.

Competitive Landscape

The major global players in the physiological saline market include: Enzo Life Sciences, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Adipogen Life Sciences, Geno Technology Inc., LABORATORIOS ERN, S.A., Grifols, S.A., Schwitz Biotech, Eurocrit Labs International and Cepham Life Sciences among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global physiological saline market. During the pandemic, the demand for physiological saline has increased. The COVID-19 pandemic led to a surge in demand for medical supplies and equipment including physiological saline. Hospitals and healthcare clinics faced increased patient loads especially those with severe respiratory symptoms, necessitating greater use of these physiological saline. The pandemic also disrupted the supply chain of the physiological saline globally.

Market Segmentation

By Packaging Type

• Plastic Bottle
• Glass Bottle
• Flexible Bag

By Application

• Dehydration
• Metabolic Alkalosis
• Mild Sodium Depletion
• Wound Cleansing
• Skin Abrasions and Burns
• Others

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Why Purchase the Report?

• To visualize the global physiological saline market segmentation based on packaging type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of physiological saline market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global physiological saline market report would provide approximately 61 tables, 61 figures, and 187 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Packaging Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Adoption in Surgical Procedures
  • 4.1.2. Restraints
    • 4.1.2.1. Side Effects of the Physiological Saline
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Pipeline Analysis
• 5.6. Unmet Needs
• 5.7. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Packaging Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 7.1.2. Market Attractiveness Index, By Packaging Type
• 7.2. Plastic Bottle*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Glass Bottle
• 7.4. Flexible Bag

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Dehydration*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Metabolic Alkalosis
• 8.4. Mild Sodium Depletion
• 8.5. Wound Cleansing
• 8.6. Skin Abrasions and Burns
• 8.7. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Ambulatory Surgical Centers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Enzo Life Sciences, Inc.*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Thermo Fisher Scientific Inc.
• 12.3. Merck KGaA
• 12.4. Adipogen Life Sciences
• 12.5. Geno Technology Inc.
• 12.6. LABORATORIOS ERN, S.A.
• 12.7. Grifols, S.A.
• 12.8. Schwitz Biotech
• 12.9. Eurocrit Labs International
• 12.10. Cepham Life Sciences

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us